Super Vilitra

Product Overview

Super Vilitra is a dual-action medication combining Vardenafil 20 mg and Dapoxetine 60 mg in tablet form. This innovative treatment simultaneously addresses erectile dysfunction (ED) and premature ejaculation (PE), providing a complete solution for men struggling with both erection maintenance and ejaculatory control during sexual activity.

Uses

Super Vilitra is clinically proven to treat:

1. Erectile Dysfunction: Facilitates achieving and sustaining firm erections through enhanced penile blood circulation
2. Premature Ejaculation: Effectively extends sexual endurance and improves ejaculatory control

How to Use

For optimal results:

1. Ingest one tablet with water 30-60 minutes prior to sexual intercourse
2. Refrain from alcohol consumption and heavy meals before administration
3. Note: Sexual arousal is required for medication efficacy

Mechanism of Action

Super Vilitra operates through synergistic pharmacological effects:

• Vardenafil (20mg): PDE5 inhibitor that enhances nitric oxide activity, promoting vasodilation and penile blood flow
• Dapoxetine (60mg): Short-acting SSRI that modulates serotonin neurotransmission to delay ejaculation

Dosage and Administration

The standard therapeutic dose is one tablet (Vardenafil 20mg/Dapoxetine 60mg) taken orally with water 30-60 minutes before sexual activity. Maximum daily intake should not exceed one tablet.

Therapeutic Benefits

• Dual treatment for ED and PE in single-dose formulation
• Improved erectile quality and duration
• Enhanced ejaculatory control and sexual stamina
• Increased sexual confidence and satisfaction
• Convenient oral administration

Common Adverse Effects

Most frequently reported side effects include:

• Cephalalgia (headache)
• Gastrointestinal discomfort (nausea)
• Vertigo (dizziness)
• Facial erythema (flushing)
• Xerostomia (dry mouth)

These transient effects typically resolve without intervention. Persistent symptoms warrant medical consultation.

Precautions

Important considerations include:

• Potential drug interactions with nitrates and antihypertensives
• Contraindications in patients with cardiovascular conditions
• Caution advised for hepatic/renal impairment patients

Safety Warnings

Super Vilitra is contraindicated in:

• Patients with hypersensitivity to active ingredients
• Women and minors (<18 years)
• Individuals with severe cardiovascular, hepatic, or psychiatric conditions

Storage Conditions

Maintain at controlled room temperature (15-30°C) in original packaging. Protect from moisture and direct sunlight. Keep securely stored away from pediatric access.

Medical Disclaimer

This information is provided for educational purposes only and represents current pharmacological knowledge. It does not constitute medical advice nor replace professional consultation. While we strive for accuracy, complete information regarding contraindications, interactions, and adverse effects may not be fully represented. Always consult with a qualified healthcare provider regarding any medical condition or treatment. This content is intended to supplement, not substitute, the physician-patient relationship.